DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs
- 15 June 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (12), 4987-4992
- https://doi.org/10.1158/0008-5472.can-04-4250
Abstract
DNA-dependent protein kinase (DNA-PK)–defective severe combined immunodeficient (SCID) mice have a greater sensitivity to ionizing radiation compared with wild-type mice due to deficient repair of DNA double-strand break. SCID cells were therefore studied to determine whether radiosensitization by the specific inhibitor of DNA-PK, IC87361, is eliminated in the absence of functional DNA-PK. IC87361 enhanced radiation sensitivity in wild-type C57BL6 endothelial cells but not in SCID cells. The tumor vascular window model was used to assess IC87361-induced radiosensitization of SCID and wild-type tumor microvasculature. Vascular density was 5% in irradiated SCID host compared with 50% in C57BL6 mice (P < 0.05). IC87361 induced radiosensitization of tumor microvasculature in wild-type mice that resembled the radiosensitive phenotype of tumor vessels in SCID mice. Radiosensitization by IC87361 was eliminated in SCID tumor vasculature, which lack functional DNA-PK. Irradiated LLC and B16F0 tumors implanted into SCID mice showed greater tumor growth delay compared with tumors implanted into either wild-type C57BL6 or nude mice. Furthermore, LLC tumors treated with radiation and IC87361 showed tumor growth delay that was significantly greater than tumors treated with radiation alone (P < 0.01 for 3 Gy alone versus 3 Gy + IC87361). DNA-PK inhibitors induced no cytotoxicity and no toxicity in mouse normal tissues. Mouse models deficient in enzyme activity are useful to assess the specificity of novel kinase inhibitors. DNA-PK is an important target for the development of novel radiation-sensitizing drugs that have little intrinsic cytotoxicity.This publication has 18 references indexed in Scilit:
- A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular DestructionCancer Research, 2004
- siRNA-silencing of DNA repair factors results in enhanced radiation and chemotherapy-mediated killing of human cancer cellsInternational Journal of Radiation Oncology*Biology*Physics, 2003
- When is a lipid kinase not a lipid kinase? When it is a protein kinaseCell, 1995
- DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene productCell, 1995
- ATM-related genes: What do they tell us about functions of the human gene?Cell, 1995
- Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutationCell, 1995
- Protein kinases and DNA damageTrends in Biochemical Sciences, 1994
- Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombinationScience, 1994
- The role of DNA double strand breaks in lonizing radiation‐induced killing of eukaryotic cellsBioEssays, 1991
- The scid mutation in mice causes a general defect in DNA repairNature, 1990